Biomet Bhs- Mini
PMA P790002
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPRL | NumberP790002 | Date6 Nov 1979 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Trade Name
- Biomet(R) EBI BONE Healing System
- Generic Name
- Stimulator, bone growth, non-invasive
- PMA Number
- FDA Product Code
- LOF
- Device Class
- Class II
- Regulation
- 21 CFR Part 890.5870
- Advisory Committee
- Orthopedic
- FDA Decision
- APRL
Overview
AI-generated summary, 18 Sep 2026
The Biomet BHS-Mini is a Stimulator, Bone Growth, Non-Invasive, classified as a Class II medical device. This device is designed to promote bone healing and regeneration through non-invasive electrical stimulation, aiding in the treatment of orthopedic conditions such as fractures or delayed unions.
The BHS-Mini is intended for use in clinical settings, supplied as a reusable device under FDA Premarket Approval (PMA P790002). It operates under regulatory framework 890.5870 and is associated with multiple registration numbers, including 3010032952 and 3027669735. No specific sterility or MRI safety information is provided in the data.
Other devices from Ahp Eos Buyer, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the Biomet BHS-Mini device, and how does it work?
The Biomet BHS-Mini is a non-invasive bone growth stimulator designed to promote bone healing and regeneration. It achieves this through electrical stimulation, which helps accelerate the treatment of orthopedic conditions like fractures or delayed unions. The device is classified as a Class II medical device and is intended for use in clinical settings to aid in skeletal recovery.
Is the Biomet BHS-Mini device single-use or reusable, and what does this mean for its maintenance?
The Biomet BHS-Mini is supplied as a reusable device, meaning it is intended for repeated use in clinical settings. Since it is not single-use, proper cleaning, maintenance, and sterilization protocols must be followed to ensure its continued safe and effective operation. No specific sterility information is provided, so facility protocols should align with standard practices for reusable medical devices.
How is the regulatory approval process for the Biomet BHS-Mini structured, and what does this imply for its use?
The Biomet BHS-Mini received FDA Premarket Approval (PMA P790002), which means it underwent a rigorous review process to demonstrate safety and effectiveness before being authorized for clinical use. This approval route is typically reserved for higher-risk devices, ensuring that the device meets stringent standards for promoting bone healing through non-invasive electrical stimulation. The device is classified under regulatory framework 890.5870.
What types of orthopedic conditions is the Biomet BHS-Mini intended to assist with, and in what setting is it used?
The Biomet BHS-Mini is specifically designed to assist with bone healing and regeneration in orthopedic conditions such as fractures or delayed unions. It is intended for use exclusively in clinical settings, where healthcare professionals can monitor and manage patient care effectively. The device is not intended for home use or self-administration.
Are there any specific storage requirements or considerations for the Biomet BHS-Mini device?
While the provided data does not specify storage requirements, as a reusable medical device, the Biomet BHS-Mini should be stored in a clean, dry environment to prevent contamination or damage. It should also be kept in a secure location to avoid exposure to extreme temperatures or physical stress. Follow manufacturer guidelines or facility protocols for optimal storage and handling.